These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22552983)

  • 1. Performance of propensity score methods when comparison groups originate from different data sources.
    Hammill BG; Curtis LH; Setoguchi S
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():81-9. PubMed ID: 22552983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of different propensity-score methods for estimating relative risks.
    Austin PC
    J Clin Epidemiol; 2008 Jun; 61(6):537-45. PubMed ID: 18471657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of different propensity score methods for estimating marginal odds ratios.
    Austin PC
    Stat Med; 2007 Jul; 26(16):3078-94. PubMed ID: 17187347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study.
    Austin PC; Grootendorst P; Normand SL; Anderson GM
    Stat Med; 2007 Feb; 26(4):754-68. PubMed ID: 16783757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confounder-adjusted estimates of the risk difference using propensity score-based weighting.
    Ukoumunne OC; Williamson E; Forbes AB; Gulliford MC; Carlin JB
    Stat Med; 2010 Dec; 29(30):3126-36. PubMed ID: 21170907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.
    Arbogast PG; Ray WA
    Am J Epidemiol; 2011 Sep; 174(5):613-20. PubMed ID: 21749976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score balance measures in pharmacoepidemiology: a simulation study.
    Ali MS; Groenwold RH; Pestman WR; Belitser SV; Roes KC; Hoes AW; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):802-11. PubMed ID: 24478163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.
    Groenwold RH; de Vries F; de Boer A; Pestman WR; Rutten FH; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1130-7. PubMed ID: 21953948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies.
    Austin PC
    Med Decis Making; 2009; 29(6):661-77. PubMed ID: 19684288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring balance and model selection in propensity score methods.
    Belitser SV; Martens EP; Pestman WR; Groenwold RH; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1115-29. PubMed ID: 21805529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-to-many propensity score matching in cohort studies.
    Rassen JA; Shelat AA; Myers J; Glynn RJ; Rothman KJ; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():69-80. PubMed ID: 22552982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study.
    Gayat E; Resche-Rigon M; Mary JY; Porcher R
    Pharm Stat; 2012; 11(3):222-9. PubMed ID: 22411785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity score methods for estimating relative risks in cluster randomized trials with low-incidence binary outcomes and selection bias.
    Leyrat C; Caille A; Donner A; Giraudeau B
    Stat Med; 2014 Sep; 33(20):3556-75. PubMed ID: 24771662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the objectives of and the approaches to propensity score analyses.
    Heinze G; Jüni P
    Eur Heart J; 2011 Jul; 32(14):1704-8. PubMed ID: 21362706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score.
    Austin PC
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1202-17. PubMed ID: 18972454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses.
    Austin PC
    Int J Biostat; 2009 Apr; 5(1):Article 13. PubMed ID: 20949126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
    Wang MH; Shugart YY; Cole SR; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):706-11. PubMed ID: 19258478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of recall errors and of selection bias in epidemiologic studies of mobile phone use and cancer risk.
    Vrijheid M; Deltour I; Krewski D; Sanchez M; Cardis E
    J Expo Sci Environ Epidemiol; 2006 Jul; 16(4):371-84. PubMed ID: 16773122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance evaluation of regression splines for propensity score adjustment in post-market safety analysis with multiple treatments.
    Tian Y; Baro E; Zhang R
    J Biopharm Stat; 2019; 29(5):810-821. PubMed ID: 31502924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.